Skip to main content
European Commission logo print header

Regulatory Science Framework for Nano(bio)material-based Medical Products and Devices

Objetivo

REFINE proposes a Regulatory Science Framework for the risk-benefit assessment of medical products and medical devices that are based on nanomedicines and biomaterials. The heart of our framework is the development of a product-specific Decision Support System that identifies the most efficient way to deliver the data required by regulation by the best-fitting methods. The decision tree will explicate the product’s specific regulatory challenges and the priorities of both missing data and missing methods to match these challenges. It will thus allow planning a cost-and time efficient strategy both for necessary measurements and for the advancement of methods. Our approach is aligned with the industrial R&D practice of stage gating.
We will demonstrate the relevance of the framework for the most pressing regulatory challenges, which are: borderline products, nanosimilars, and products combining several functionalities. In order to do so, we will identify the regulatory challenges with Regulation Authorities from Europe and abroad, and design methods for tiered decision tree, guided by the latest scientific knowledge. We will study/predict physiological distribution of nanomedicines and biomaterials, as well as develop and validate new analytical or experimental methods and assays requested by the regulators. These latter development will be performed in a quality management system, ensuring the possible standardisation of our assays.
REFINE will gather a wide community of stakeholders in regulation, industry, science, technology development, patients, and end-users, into a Consortium for the Advancement of Regulatory Science in Biomaterials and Nanomedicine.

Convocatoria de propuestas

H2020-NMBP-2016-2017

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-NMBP-2017-two-stage

Régimen de financiación

RIA - Research and Innovation action

Coordinador

GESELLSCHAFT FUR BIOANALYTIK MUNSTER EV
Aportación neta de la UEn
€ 250 437,50
Dirección
MENDELSTRASSE 17
48149 Munster
Alemania

Ver en el mapa

Región
Nordrhein-Westfalen Münster Münster, Kreisfreie Stadt
Tipo de actividad
Research Organisations
Enlaces
Coste total
€ 819 500,00

Participantes (17)